UK partners with Atomwise to screen for potential drugs against novel COVID-19 target

(University of Kentucky) The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.